The National Medical Weight Loss Programme
What is it?
The National Medical Weight Loss Programme (NMWLP) uses an FDA approved medication called liraglutide, which is licensed for weight loss under the trade name of Saxenda®. Saxenda® has passed numerous clinical trials for safety, and is the only approved injectable prescription medicine available in the UK for weight loss.
How does it work?
Liraglutide mimics the action of the body’s natural hormone (GLP-1) which regulates appetite and food intake. GLP-1 makes you feel full, hence your appetite is reduced. It also delays the time it takes for the stomach to empty, keeping you feeling full and satisfied (sated) for longer. Both of these actions lead to lower calorie intake and subsequent weight loss.
By reducing your appetite, the NMWLP will help you keep to the calorie-controlled diet of your choice (e.g. Weight Watchers, Slimming World, Atkins, 5:2, or Keto etc) in order to easily achieve your weight loss goals
Additionally, by losing weight you are reducing your risk of developing heart disease, high blood pressure, type 2 diabetes and more importantly, to help you feel happier and healthier.
How is it given?
A simple and painless injection is self-administered each day using an easy-to-use, dose-adjustable pen (see below) that is pre-filled with the medication.
Who can take it?
The NMWLP uses a medication that is prescribed for weight loss, and used in conjunction with diet and exercise in adults aged 18 – 75, who have a BMI of 30 or above, or a BMI of 27 when there are any other weight-related health issues present such as high blood pressure, abnormal levels of fats in the blood (lipids), or breathing problems during sleep (obstructive sleep apnoea).
Additionally, if any of the following apply, you will not be suitable for the Programme;
* Pregnant, trying to get pregnant or breast feeding
* Inflammatory bowel disease
* History of thyroid cancer
* History of pancreatitis
* Severe kidney disease
* Severe heart failure
* Taking insulin
Are there any side-effects?
As with any new medication, following the NMWLP may result in some short-term side effects. The most common side effects are nausea, indigestion, constipation or diarrhoea. However, these usually settle within the first few days. Please remember, our team are always on hand to answer any questions or concerns you may have.
How much do I need?
Each Pen contains 18mg of liraglutide. Every patient starts on 0.6mg daily for the first week. If the desired outcomes are achieved on this dose i.e. not feeling hungry or craving things (so you don’t cheat on your diet) then this dose can be maintained. If on the other hand, your appetite is not fully controlled, then the dose should be increased by 0.6mg per day for a further week. This pattern can be repeated each week until the desired effects are achieved, but only up to a maximum of 3.0mg daily
One pen can last up to 4 weeks depending on the daily dose required to achieve the desired outcomes.
How can I get it?
The NMWLP uses a prescription medication, and you must complete a medical assessment to ensure it is safe for you to use it.
Simply call or email the Clinic to make an appointment or discuss any further questions you may have.